301333 诺思格
已收盘 01-12 15:00:00
资讯
新帖
简况
股市必读：诺思格（301333）1月7日董秘有最新回复
中金财经 · 01-08
股市必读：诺思格（301333）1月7日董秘有最新回复
股市必读：诺思格（301333）1月6日董秘有最新回复
证券之星 · 01-07
股市必读：诺思格（301333）1月6日董秘有最新回复
诺思格：合作涉及美国、欧洲、日本、韩国
证券之星 · 01-06
诺思格：合作涉及美国、欧洲、日本、韩国
每周股票复盘：诺思格（301333）董事减持3100股并选举为职工代表董事
证券之星 · 01-03
每周股票复盘：诺思格（301333）董事减持3100股并选举为职工代表董事
诺思格：12月29日高管乔宇航减持股份合计3100股
证券之星 · 2025-12-30
诺思格：12月29日高管乔宇航减持股份合计3100股
诺思格（301333）披露选举第五届董事会职工代表董事，12月29日股价上涨5.21%
证券之星 · 2025-12-29
诺思格（301333）披露选举第五届董事会职工代表董事，12月29日股价上涨5.21%
12月29日诺思格涨5.21%，信澳优享生活混合A基金重仓该股
证券之星 · 2025-12-29
12月29日诺思格涨5.21%，信澳优享生活混合A基金重仓该股
诺思格涨5.21%，太平洋一个月前给出“买入”评级
证券之星 · 2025-12-29
诺思格涨5.21%，太平洋一个月前给出“买入”评级
诺思格（301333）披露2024年员工持股计划第一个锁定期届满暨解锁条件成就的提示性公告，12月22日股价上涨1.02%
证券之星 · 2025-12-22
诺思格（301333）披露2024年员工持股计划第一个锁定期届满暨解锁条件成就的提示性公告，12月22日股价上涨1.02%
诺思格（301333）披露召开2025年第三次临时股东大会通知，12月09日股价上涨0.38%
证券之星 · 2025-12-09
诺思格（301333）披露召开2025年第三次临时股东大会通知，12月09日股价上涨0.38%
11月18日诺思格现1笔折价19.44%的大宗交易 合计成交207.58万元
证券之星 · 2025-11-18
11月18日诺思格现1笔折价19.44%的大宗交易 合计成交207.58万元
诺思格：自主研发Ai平台提高医药研发效率
证券之星 · 2025-11-05
诺思格：自主研发Ai平台提高医药研发效率
股市必读：诺思格（301333）登10月31日交易所龙虎榜
证券之星 · 2025-11-03
股市必读：诺思格（301333）登10月31日交易所龙虎榜
10月31日诺思格（301333）龙虎榜数据：机构净买入1.05亿元（3日），北向资金净买入2639.4万元（3日）
证券之星 · 2025-10-31
10月31日诺思格（301333）龙虎榜数据：机构净买入1.05亿元（3日），北向资金净买入2639.4万元（3日）
诺思格最新公告：公司经营情况正常无应披露而未披露的重大事项
证券之星 · 2025-10-31
诺思格最新公告：公司经营情况正常无应披露而未披露的重大事项
诺思格（301333）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 2025-10-30
诺思格（301333）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
股市必读：诺思格10月29日涨停收盘，收盘价61.92元
证券之星 · 2025-10-30
股市必读：诺思格10月29日涨停收盘，收盘价61.92元
诺思格(301333.SZ)发布前三季度业绩，归母净利润9556.68万元，增长13.21%
智通财经 · 2025-10-28
诺思格(301333.SZ)发布前三季度业绩，归母净利润9556.68万元，增长13.21%
诺思格（301333）披露2025年第三季度报告，10月28日股价上涨0.39%
证券之星 · 2025-10-28
诺思格（301333）披露2025年第三季度报告，10月28日股价上涨0.39%
诺思格新注册《医药试验数据标准化平台V1.0》项目的软件著作权
证券之星 · 2025-10-24
诺思格新注册《医药试验数据标准化平台V1.0》项目的软件著作权
加载更多
公司概况
公司名称：
诺思格(北京)医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-08-02
主营业务：
诺思格(北京)医药科技股份有限公司的主营业务是为全球的医药企业和科研机构提供综合的药物临床研发全流程一体化服务。公司的主要产品是药物临床。
发行价格：
78.88
{"stockData":{"symbol":"301333","market":"SZ","secType":"STK","nameCN":"诺思格","latestPrice":63.73,"timestamp":1768201425000,"preClose":65.09,"halted":0,"volume":2211614,"delay":0,"changeRate":-0.0209,"floatShares":57170200,"shares":96581299,"eps":1.5673,"marketStatus":"已收盘","change":-1.36,"latestTime":"01-12 15:00:00","open":64.5,"high":64.78,"low":63.2,"amount":141000000,"amplitude":0.0243,"askPrice":63.78,"askSize":2,"bidPrice":63.73,"bidSize":62,"shortable":0,"etf":0,"ttmEps":1.5673,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768267800000},"marketStatusCode":5,"adr":0,"adjPreClose":65.09,"symbolType":"stock","openAndCloseTimeList":[[1768181400000,1768188600000],[1768194000000,1768201200000]],"highLimit":71.6,"lowLimit":58.58,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":96581256,"isCdr":false,"pbRate":3.27,"roa":"--","peRate":40.662285,"roe":"5.08%","epsLYR":1.47,"committee":0.448889,"marketValue":6155000000,"turnoverRate":0.0387,"status":1,"floatMarketCap":3643000000},"requestUrl":"/m/hq/s/301333","defaultTab":"news","newsList":[{"id":"2601877003","title":"股市必读：诺思格（301333）1月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601877003","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601877003?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:06","pubTimestamp":1767830766,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年1月7日收盘，诺思格报收于61.68元，上涨0.19%，换手率4.19%，成交量2.4万手，成交额1.5亿元。其中欧洲市场主要和哪些国家合作呢？鉴于公司与客户普遍签署保密协议，不便披露具体信息。 来自交易信息汇总：1月7日主力资金净流入194.46万元，显示主力对个股短期态度偏积极。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260108/31924265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2601817031","title":"股市必读：诺思格（301333）1月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601817031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601817031?lang=zh_cn&edition=full","pubTime":"2026-01-07 03:21","pubTimestamp":1767727270,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，诺思格报收于61.56元，下跌0.36%，换手率3.51%，成交量2.0万手，成交额1.23亿元。董秘最新回复投资者： 公司已为国内外众多优质客户的多项临床试验项目提供符合国内外标准的临床试验外包服务，请问公司具体合作的海外国家有哪些？公司与海外多个药企有合作，主要涉及美国、欧洲、日本、韩国等。交易信息汇总资金流向1月6日主力资金净流出424.23万元；游资资金净流入648.3万元；散户资金净流出224.07万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700001481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2601861838","title":"诺思格：合作涉及美国、欧洲、日本、韩国","url":"https://stock-news.laohu8.com/highlight/detail?id=2601861838","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601861838?lang=zh_cn&edition=full","pubTime":"2026-01-06 15:03","pubTimestamp":1767682993,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格(301333)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问：公司已为国内外众多优质客户的多项临床试验项目提供符合国内外标准的临床试验外包服务，请问公司具体合作的海外国家有哪些？诺思格回复：尊敬的投资者您好！公司与海外多个药企有合作，主要涉及美国、欧洲、日本、韩国等。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600019749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2600060360","title":"每周股票复盘：诺思格（301333）董事减持3100股并选举为职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2600060360","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600060360?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:33","pubTimestamp":1767382390,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，诺思格报收于59.55元，较上周的58.37元上涨2.02%。股本股东变化高管增减持2025年12月29日，诺思格董事乔宇航减持公司股份3100.0股，占公司总股本的0.0032%。公司公告汇总关于选举第五届董事会职工代表董事的公告2025年12月29日，诺思格召开职工代表大会，选举乔宇航为第五届董事会职工代表董事，任期至本届董事会届满。董事会中兼任高管及职工代表董事人数未超过董事总数的二分之一，符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2595797371","title":"诺思格：12月29日高管乔宇航减持股份合计3100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595797371","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595797371?lang=zh_cn&edition=full","pubTime":"2025-12-30 21:03","pubTimestamp":1767099817,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月30日市场公开信息、上市公司公告及交易所披露数据整理，诺思格最新董监高及相关人员股份变动情况：2025年12月29日公司董事乔宇航共减持公司股份3100.0股，占公司总股本为0.0032%。变动期间公司股价上涨5.21%，12月29日当日收盘报61.41元。诺思格近半年内的董监高及核心技术人员增减持详情如下：诺思格的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出266.68万，融资余额减少；融券净流出100.0，融券余额减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000041313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2595773524","title":"诺思格（301333）披露选举第五届董事会职工代表董事，12月29日股价上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595773524","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595773524?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:24","pubTimestamp":1767018261,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，诺思格报收于61.41元，较前一交易日上涨5.21%，最新总市值为59.31亿元。公司近日发布公告称，诺思格（北京）医药科技股份有限公司于2025年12月29日召开职工代表大会，选举乔宇航先生为公司第五届董事会职工代表董事，任期自审议通过之日起至第五届董事会任期届满。本次选举后，公司董事会中兼任高管及职工代表董事人数未超过董事总数的二分之一，符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900037917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2595120708","title":"12月29日诺思格涨5.21%，信澳优享生活混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595120708","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595120708?lang=zh_cn&edition=full","pubTime":"2025-12-29 15:39","pubTimestamp":1766993943,"startTime":"0","endTime":"0","summary":"证券之星消息，12月29日诺思格涨5.21%，收盘报61.41元，换手率7.49%，成交量4.28万手，成交额2.6亿元。重仓诺思格的公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级3家，增持评级2家；过去90天内机构目标均价为88.4。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为信达澳亚基金的信澳优享生活混合A。该公募基金现任基金经理为杨珂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900014582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK1597","BK1553","BK1500","BK1237","01717","BK0216"],"gpt_icon":0},{"id":"2595055207","title":"诺思格涨5.21%，太平洋一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2595055207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595055207?lang=zh_cn&edition=full","pubTime":"2025-12-29 15:38","pubTimestamp":1766993935,"startTime":"0","endTime":"0","summary":"今日诺思格涨5.21%，收盘报61.41元。2025年10月31日，太平洋研究员周豫,张崴发布了对诺思格的研报《Q3收入稳健增长，利润增速超预期》，该研报对诺思格给出“买入”评级。研报中预计2025年-2027年公司营收为7.76/8.52/9.69亿元，同比增长4.33%/9.75%/13.79%；归母净利为1.50/1.63/1.81亿元，同比增长6.85%/8.83%/11.26%，对应PE为33/31/28倍，持续给予“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为太平洋的周豫、张崴。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900014577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","601099"],"gpt_icon":0},{"id":"2593485716","title":"诺思格（301333）披露2024年员工持股计划第一个锁定期届满暨解锁条件成就的提示性公告，12月22日股价上涨1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593485716","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593485716?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:54","pubTimestamp":1766397273,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘，诺思格报收于58.23元，较前一交易日上涨1.02%，最新总市值为56.24亿元。公告称，公司于2025年12月22日召开董事会，审议通过2024年员工持股计划第一个锁定期届满暨解锁条件成就的议案。本计划第一个锁定期于2025年12月23日届满，解锁日期为12月24日，对应50%的标的股票即233,100股，占公司总股本的0.24%。解锁条件根据持有人绩效考核结果确定，考核等级为优秀或良好的归属比例为100%。公司董事会薪酬与考核委员会确认本次解锁符合条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200022813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2590342382","title":"诺思格（301333）披露召开2025年第三次临时股东大会通知，12月09日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590342382","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590342382?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:20","pubTimestamp":1765290007,"startTime":"0","endTime":"0","summary":"截至2025年12月9日收盘，诺思格报收于55.75元，较前一交易日上涨0.38%，最新总市值为53.84亿元。该股当日开盘55.36元，最高56.92元，最低55.19元，成交额达1.03亿元，换手率为3.21%。近日，诺思格（北京）医药科技股份有限公司发布公告，宣布将于2025年12月29日召开2025年第三次临时股东大会，会议采取现场表决与网络投票相结合的方式。股权登记日为2025年12月23日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900040733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2584987534","title":"11月18日诺思格现1笔折价19.44%的大宗交易 合计成交207.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584987534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584987534?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:48","pubTimestamp":1763455709,"startTime":"0","endTime":"0","summary":"证券之星消息，11月18日诺思格发生大宗交易，交易数据如下：大宗交易成交价格48.5元，相对当日收盘价折价19.44%，成交4.28万股，成交金额207.58万元，买方营业部为方正证券股份有限公司上海杨高南路证券营业部，卖方营业部为华福证券有限责任公司苏州分公司。近三个月该股共发生1笔大宗交易，合计成交428.0手，折价成交1笔。截至2025年11月18日收盘，诺思格报收于60.2元，下跌0.63%，换手率4.76%，成交量2.72万手，成交额1.66亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800020692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2581069715","title":"诺思格：自主研发Ai平台提高医药研发效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2581069715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581069715?lang=zh_cn&edition=full","pubTime":"2025-11-05 11:36","pubTimestamp":1762313766,"startTime":"0","endTime":"0","summary":"证券之星消息，诺思格(301333)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：现在AI越来越强大，想必在创新药领域也可以有很大发展空间，目前公司的AI平台为公司带来哪些优势？公司有持续投入AI平台的创新与迭代吗？诺思格回复：尊敬的投资者您好！公司密切关注Ai技术，自主研发Ai平台，以提高医药研发外包服务效率。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500014025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0216","BK1574","159938","09939","301333","BK1515"],"gpt_icon":0},{"id":"2580459231","title":"股市必读：诺思格（301333）登10月31日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2580459231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580459231?lang=zh_cn&edition=full","pubTime":"2025-11-03 06:04","pubTimestamp":1762121061,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，诺思格报收于68.59元，上涨7.0%，换手率14.44%，成交量8.25万手，成交额5.58亿元。龙虎榜上榜沪深交易所2025年10月31日公布的交易公开信息显示，诺思格因连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。公司公告汇总股票交易异常波动公告诺思格（北京）医药科技股份有限公司股票于2025年10月29日、10月30日、10月31日连续三个交易日收盘价格涨幅偏离值累计超过30%，属于股票交易异常波动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300001299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2579454803","title":"10月31日诺思格（301333）龙虎榜数据：机构净买入1.05亿元（3日），北向资金净买入2639.4万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2579454803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579454803?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:47","pubTimestamp":1761904034,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年10月31日公布的交易公开信息显示，诺思格因连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年10月31日收盘，诺思格报收于68.59元，上涨7.0%，换手率14.44%，成交量8.25万手，成交额5.58亿元。从龙虎榜公布的三日买卖数据来看，机构合计净买入1.05亿元，北向资金合计净买入2639.4万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100037723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2579945963","title":"诺思格最新公告：公司经营情况正常无应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2579945963","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579945963?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:17","pubTimestamp":1761902279,"startTime":"0","endTime":"0","summary":"诺思格(301333.SZ)公告称，公司股票于2025年10月29日至10月31日连续三个交易日收盘价格涨幅偏离值累计超过30%，属于股票交易异常波动情况。经核实，公司前期披露的信息无需要更正或补充之处，近期公共传媒未报道可能影响公司股价的重大信息，公司经营环境未发生重大变化。公司、控股股东和实际控制人无应披露而未披露的重大事项或筹划中的事项。控股股东和实际控制人在股票交易异常波动期间未买卖公司股票。公司将继续履行信息披露义务，相关信息以指定媒体刊登为准。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100035599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2579581651","title":"诺思格（301333）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2579581651","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579581651?lang=zh_cn&edition=full","pubTime":"2025-10-30 06:43","pubTimestamp":1761777797,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期诺思格发布2025年三季报。截至本报告期末，公司营业总收入6.07亿元，同比上升8.09%，归母净利润9556.68万元，同比上升13.21%。本报告期诺思格公司应收账款体量较大，当期应收账款占最新年报归母净利润比达97.94%。去年的净利率为19.06%，算上全部成本后，公司产品或服务的附加值高。持有诺思格最多的基金为信澳优享生活混合A，目前规模为1.92亿元，最新净值1.1259，较上一交易日上涨1.54%，近一年上涨41.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000007132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333"],"gpt_icon":0},{"id":"2579600181","title":"股市必读：诺思格10月29日涨停收盘，收盘价61.92元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579600181","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579600181?lang=zh_cn&edition=full","pubTime":"2025-10-30 01:37","pubTimestamp":1761759474,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘，诺思格报收于61.92元，上涨20.0%，涨停，换手率16.62%，成交量9.5万手，成交额5.58亿元。当日关注点来自交易信息汇总：诺思格10月29日涨停收盘，收盘价61.92元，盘中7次打开涨停，最终封单资金为723.1万元。来自龙虎榜上榜：诺思格因日涨幅达15%登龙虎榜，为近5个交易日内首次上榜。交易信息汇总诺思格10月29日涨停收盘，收盘价61.92元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000001886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301333"],"gpt_icon":0},{"id":"2578342934","title":"诺思格(301333.SZ)发布前三季度业绩，归母净利润9556.68万元，增长13.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578342934","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578342934?lang=zh_cn&edition=full","pubTime":"2025-10-28 18:00","pubTimestamp":1761645637,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺思格(301333.SZ)发布2025年三季度报告，该公司前三季度营业收入为6.07亿元，同比增长8.09%。归属于上市公司股东的净利润为9556.68万元，同比增长13.21%。归属于上市公司股东的扣除非经常性损益的净利润为8133.34万元，同比增长22.47%。基本每股收益为1元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301333"],"gpt_icon":0},{"id":"2578893149","title":"诺思格（301333）披露2025年第三季度报告，10月28日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578893149","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578893149?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:53","pubTimestamp":1761645216,"startTime":"0","endTime":"0","summary":"截至2025年10月28日收盘，诺思格报收于51.6元，较前一交易日上涨0.39%，最新总市值为49.84亿元。公司近日发布公告称，诺思格（北京）医药科技股份有限公司第四届监事会第十一次会议于2025年10月28日以现场结合通讯方式召开，会议审议通过《关于<2025年第三季度报告全文>的议案》。监事会认为公司《2025年第三季度报告》内容真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏。相关内容详见公司同日披露于巨潮资讯网的《2025年第三季度报告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800033362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301333","BK0216"],"gpt_icon":0},{"id":"2577827975","title":"诺思格新注册《医药试验数据标准化平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2577827975","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577827975?lang=zh_cn&edition=full","pubTime":"2025-10-24 01:38","pubTimestamp":1761241090,"startTime":"0","endTime":"0","summary":"证券之星消息，近日诺思格（301333）新注册了《医药试验数据标准化平台V1.0》项目的软件著作权。今年以来诺思格新注册软件著作权2个，较去年同期减少了66.67%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了3067.26万元，同比增8.59%。通过天眼查大数据分析，诺思格（北京）医药科技股份有限公司共对外投资了7家企业，参与招投标项目10次；财产线索方面有商标信息9条，专利信息3条，著作权信息66条；此外企业还拥有行政许可4个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400001397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1515","BK1574","BK1161","BK0216","09939","301333"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768205733234,"stockEarnings":[{"period":"1week","weight":0.093},{"period":"1month","weight":0.1142},{"period":"3month","weight":0.2379},{"period":"6month","weight":0.2472},{"period":"1year","weight":0.4014},{"period":"ytd","weight":0.093}],"compareEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0.0564},{"period":"3month","weight":0.0573},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.2831},{"period":"ytd","weight":0.0382}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"诺思格(北京)医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"8734人(较上一季度减少16.18%)","perCapita":"6545股","listingDate":"2022-08-02","address":"北京市通州区经济开发区东区创益西路518号","registeredCapital":"9658万元","survey":" 诺思格(北京)医药科技股份有限公司的主营业务是为全球的医药企业和科研机构提供综合的药物临床研发全流程一体化服务。公司的主要产品是药物临床。","listedPrice":78.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺思格(301333)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺思格,301333,诺思格股票,诺思格股票老虎,诺思格股票老虎国际,诺思格行情,诺思格股票行情,诺思格股价,诺思格股市,诺思格股票价格,诺思格股票交易,诺思格股票购买,诺思格股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺思格(301333)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺思格(301333)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}